By Alexander Bueso
Date: Monday 14 Sep 2020
(Sharecast News) - European stocks finished the session on a mixed note, despite news at the weekend that AstraZeneca has resumed the key clinical trial for the Covid-19 vaccine candidate that it's developing with the University of Oxford.
No recent information was found.
| Currency | Euro |
| Share Price | 278.61 |
| Change Today | -6.39 |
| % Change | -2.24 % |
| 52 Week High | 330.00 |
| 52 Week Low | 184.20 |
| Volume | 9,666 |
| Shares Issued | 8.35m |
| Market Cap | 2,326.05m |
| Beta | 0.61 |
| Time | Volume / Share Price |
| 17:14 | 1 @ 278.80 |
| 17:13 | 20 @ 278.60 |
| 17:13 | 3 @ 278.80 |
| 17:13 | 28 @ 278.80 |
| 17:13 | 6 @ 278.80 |
You are here: research